NSE · Healthcare · Drug Manufacturers - Specialty & Generic
| Document | Date |
|---|---|
| Quarterly results · Q1 FY27 ALPA LABORATORIES LTD - FINANCIAL SUMMARY Q1 FY2027 (Quarter ended 30 June 2026) --- HEADLINE NUMBERS • Standalone Revenue from Operations (Q1 FY27 | 2026-08-13 |
| Quarterly results | 2026-07-27 |
| Quarterly results · Q4 FY26 ALPA LABORATORIES LTD – FINANCIAL SUMMARY HEADLINE NUMBERS • FY2026 Standalone Revenue from Operations: Rs. 10,580.6 lakhs (down from Rs. 11,164.49 | 2026-05-29 |
| Quarterly results · Q3 FY26 ALPA LABORATORIES LTD – FINANCIAL SUMMARY Q3 FY2025-26 Results (9 Months Ended 31 December 2025) --- HEADLINE NUMBERS • Nine Months Revenue (Standa | 2026-02-11 |
| Quarterly results · Q2 FY26 ALPA LABORATORIES LIMITED - Q2 FY2025-26 FINANCIAL SUMMARY HEADLINE NUMBERS • Quarter Ended 30 September 2025 (Standalone): Revenue from operations | 2025-11-15 |
| Annual report FY2025 ALPA LABORATORIES LIMITED – ANNUAL REPORT FY 2024-25 SUMMARY HEADLINE NUMBERS • Company: Alpa Laboratories Limited, headquartered in Indore, India • | 2025-09-04 |
| Quarterly results · Q1 FY26 ALPA LABORATORIES LTD – FINANCIAL SUMMARY Q1 FY2025-26 HEADLINE NUMBERS • Q1 FY2026 Standalone Revenue from Operations: ₹1,911.07 lacs (vs ₹2,144.37 | 2025-08-13 |
| Quarterly results | 2025-03-19 |
Readable in the app.
Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Alpa Laboratories Limited — free to start.
Open in the appGoogle PlayApp StoreData updated 2026-10-19.